Fortress Biotech (FBIO) Other Non Operating Income (2014 - 2026)

Fortress Biotech's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$27.2 million for Q4 2025.

• In Q4 2025, Other Non Operating Income fell 82372.73% year-over-year to -$27.2 million; the TTM figure through Dec 2025 stood at $17.6 million (up 1192.09% YoY), while the FY2025 annual figure was -$23000.0, down 169.7% from the prior year.
• Other Non Operating Income for Q4 2025 stood at -$27.2 million, down from $17.7 million in the prior quarter.
• The five-year high for Other Non Operating Income was $27.1 million in Q2 2025, with the low at -$39.3 million in Q4 2021.
• The 5-year median for Other Non Operating Income is $349500.0 (2023), against an average of $1.1 million.
• Peak annual rise in Other Non Operating Income reached 9519.5% in 2025, while the deepest fall reached 82372.73% in 2025.
• Fortress Biotech's Other Non Operating Income stood at -$39.3 million in 2021, then jumped by 98.35% to -$648000.0 in 2022, then plunged by 108.95% to -$1.4 million in 2023, then soared by 102.44% to $33000.0 in 2024, then sank by 82372.73% to -$27.2 million in 2025.
• Business Quant data shows FBIO's Other Non Operating Income at -$27.2 million in Q4 2025, $17.7 million in Q3 2025, and $27.1 million in Q2 2025.